The Wall Street Journal
@WSJ
Sign up for our newsletters and alerts: | Got a tip? | For WSJ customer support:
Joined April 2007
1.1K Following 22.3M Followers
A committee said the volrustomig combination was unlikely to reach either of the primary endpoints for the trial, but the company said other Phase 3 volrustomig trials would continue as planned.
Show more
